BOLD Competitors & Alternatives
Compare Boundless Bio, Inc. Common Stock with similar stocks in the same industry
Biotechnology
BOLD
Main Stock$2.32
-2.52%
Tradestie Score
33
Market Cap
$27.53M
Analyst Upside
+72.4%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 1/10
Other
Drug Design
Major Customers
2
oncology research institutions
future hospital systems
Critical Suppliers
3
CROs
CDMOs
raw material suppliers
Direct Ecosystem Rivals
0
Sole-source / monopoly positioning in sub-sector.
Top Competitors
213 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DERM
Journey Medical Corporation Common Stock
|
$3.30
-7.04%
|
$190.75M | - | 39 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.99
+0.03%
|
$180.53M | - | 54 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.78
+0.89%
|
$158.43M | - | 56 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$19.39
-2.27%
|
$154.27M | - | 38 | Compare |
|
OBIO
Orchestra BioMed Holdings, Inc. Ordinary Shares
|
$6.58
-6.00%
|
$137.59M | - | 36 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$9.19
-0.97%
|
$133.50M | - | 42 | Compare |
|
SRZN
Surrozen, Inc. Common
|
$28.46
-7.21%
|
$117.07M | - | 34 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$25.37
-4.30%
|
$110.20M | - | 44 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.31
+0.76%
|
$84.52M | - | 40 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$6.96
-1.14%
|
$67.94M | - | 48 | Compare |
More BOLD Analysis
Data updated: Nov 22, 2026 | Industry: Biotechnology (SIC 2834)
213 stocks in this industry